Minimal infective dose of attenuated poliovirus for man.
作者信息
Katz M, Plotkin S A
出版信息
Am J Public Health Nations Health. 1967 Oct;57(10):1837-40. doi: 10.2105/ajph.57.10.1837.
Abstract
摘要
相似文献
1
Minimal infective dose of attenuated poliovirus for man.人用减毒脊髓灰质炎病毒的最小感染剂量
Am J Public Health Nations Health. 1967 Oct;57(10):1837-40. doi: 10.2105/ajph.57.10.1837.
2
Response to a wild poliovirus type 2 (WPV2)-shedding event following accidental exposure to WPV2, the Netherlands, April 2017.2017年4月荷兰意外接触野生2型脊髓灰质炎病毒（WPV2）后对WPV2排毒事件的应对措施
Euro Surveill. 2017 May 25;22(21). doi: 10.2807/1560-7917.ES.2017.22.21.30542.
3
Reassessment of the place of inactivated poliomyelitis vaccine in national immunization programmes.
Dev Biol Stand. 1981;47:275-82.
4
5
Fractional-dose inactivated poliovirus vaccination campaign, Telangana state, India, June 2016.2016年6月，印度特伦甘纳邦小剂量灭活脊髓灰质炎疫苗接种活动
Wkly Epidemiol Rec. 2016 Aug 26;91(34):397-403.
6
Risk assessment, risk management and risk-based monitoring following a reported accidental release of poliovirus in Belgium, September to November 2014.2014 年 9 月至 11 月，比利时报告一起意外的脊髓灰质炎病毒释放事件后的风险评估、风险管理和基于风险的监测。
Euro Surveill. 2016;21(11):30169. doi: 10.2807/1560-7917.ES.2016.21.11.30169.
7
[Poliomyelitis vaccination, Sabin type, in 1-month-old and 3-month-old infants].
Rev Inst Med Trop Sao Paulo. 1968 Nov-Dec;10(6):376-82.
8
9
Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.当前全球消灭脊灰和控制政策选择：模型视角和停用口服脊灰疫苗的前提条件。
Expert Rev Vaccines. 2012 Apr;11(4):449-59. doi: 10.1586/erv.11.195.
10
Polio vaccines: WHO position paper – March, 2016.脊髓灰质炎疫苗：世界卫生组织立场文件 - 2016年3月
Wkly Epidemiol Rec. 2016 Mar 25;91(12):145-68.
引用本文的文献
1
Antiviral Activity of Natural Compounds for Food Safety.天然化合物在食品安全中的抗病毒活性。
Food Environ Virol. 2024 Sep;16(3):280-296. doi: 10.1007/s12560-024-09605-3. Epub 2024 Jun 17.
2
Minimum Infective Dose of the Major Human Respiratory and Enteric Viruses Transmitted Through Food and the Environment.通过食物和环境传播的主要人类呼吸道和肠道病毒的最小感染剂量
Food Environ Virol. 2011 Mar;3(1):1-30. doi: 10.1007/s12560-011-9056-7. Epub 2011 Mar 16.
3
Viral immunity. Transkingdom control of viral infection and immunity in the mammalian intestine.病毒免疫。哺乳动物肠道中病毒感染与免疫的跨界调控。
Science. 2016 Jan 15;351(6270). doi: 10.1126/science.aad5872. Epub 2016 Jan 14.
4
Risk assessment in shellfish-borne outbreaks of hepatitis A.贝类相关甲型肝炎爆发的风险评估。
Appl Environ Microbiol. 2009 Dec;75(23):7350-5. doi: 10.1128/AEM.01177-09. Epub 2009 Oct 9.
5
Effects of promyelocytic leukemia protein on virus-host balance.早幼粒细胞白血病蛋白对病毒-宿主平衡的影响。
J Virol. 2002 Apr;76(8):3810-8. doi: 10.1128/jvi.76.8.3810-3818.2002.
6
Human infective dose determinations for oral poliovirus type 1 vaccine in infants.婴儿口服脊髓灰质炎1型疫苗的人体感染剂量测定
J Clin Microbiol. 1981 Feb;13(2):388-9. doi: 10.1128/jcm.13.2.388-389.1981.
7
Removal of viruses from sewage, effluents and waters. 2. Present and future trends.从污水、废水和水体中去除病毒。2. 现状与未来趋势。
Bull World Health Organ. 1973;49(5):461-9.
8
Recovery of small quantities of viruses from clean waters on cellulose nitrate membrane filters.从硝酸纤维素膜滤器上的清洁水中回收少量病毒。
Appl Microbiol. 1971 Oct;22(4):608-14. doi: 10.1128/am.22.4.608-614.1971.
9
Validity of fecal coliforms, total coliforms, and fecal streptococci as indicators of viruses in chlorinated primary sewage effluents.粪大肠菌群、总大肠菌群和粪链球菌作为氯化初级污水排放中病毒指标的有效性。
Appl Environ Microbiol. 1978 Dec;36(6):880-4. doi: 10.1128/aem.36.6.880-884.1978.
本文引用的文献
1
The response of premature infants to infection with attenuated poliovirus.早产儿对减毒脊髓灰质炎病毒感染的反应。
Pediatrics. 1962 May;29:794-807.
2
Clinical trials in infants of orally administered attenuated poliomyelitis viruses.口服减毒脊髓灰质炎病毒在婴儿中的临床试验。
Pediatrics. 1959 Jun;23(6):1041-62.
3
Present status of attenuated live-virus poliomyelitis vaccine.减毒活疫苗脊髓灰质炎疫苗的现状。
J Am Med Assoc. 1956 Dec 29;162(18):1589-96. doi: 10.1001/jama.1956.02970350005002.
4
Clinical investigations on attenuated strains of poliomyelitis virus; use as a method of immunization of children with living virus.脊髓灰质炎病毒减毒株的临床研究；用作儿童活病毒免疫方法。
J Am Med Assoc. 1956 Mar 17;160(11):954-66. doi: 10.1001/jama.1956.02960460032008.
5
Living attenuated poliomyelitis virus as an immunizing agent of man.减毒活脊髓灰质炎病毒作为人类免疫制剂
S Afr Med J. 1955 Oct 29;29(49):1134-42.
Zotero 插件